Centre de Regulacio Genomica-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Centre de Regulacio Genomica - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013158
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre de Regulacio Genomica (CRG) is a biomedical institute that provides research services. The institute provides research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offers facilities such as light microscopy unit, bioinformatics unit, biomolecular screening, protein technologies unit, and others. CRG provides units including genomics unit, histology unit and scientific information technologies. The institute offers courses for undergraduates, PhD students, postdoctoral, researchers and scientists. It also provides technology transfer services. The institute operates through genomics unit, tissue engineering unit and in-house services. CRG is headquartered in Barcelona, Spain.

Centre de Regulacio Genomica – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Centre for Genomic Regulation Enters Into Co-Development Agreement With Illumina 9
Centre For Genomic Regulation Enters Into Research Agreement With Sanofi 10
Centre de Regulacio Genomica Enters Into Research Agreement With Sanofi 11
Centre de Regulacio Genomica – Key Competitors 12
Centre de Regulacio Genomica – Key Employees 13
Centre de Regulacio Genomica – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Key Facts 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre de Regulacio Genomica, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Centre for Genomic Regulation Enters Into Co-Development Agreement With Illumina 9
Centre For Genomic Regulation Enters Into Research Agreement With Sanofi 10
Centre de Regulacio Genomica Enters Into Research Agreement With Sanofi 11
Centre de Regulacio Genomica, Key Competitors 12
Centre de Regulacio Genomica, Key Employees 13

★海外企業調査レポート[Centre de Regulacio Genomica-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Danieli & C. Officine Meccaniche SpA:企業の戦略・SWOT・財務分析
    Danieli & C. Officine Meccaniche SpA - Strategy, SWOT and Corporate Finance Report Summary Danieli & C. Officine Meccaniche SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Oil India Ltd (OIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil India Ltd (OIL) is an integrated upstream petroleum company which explores, develops, and produces crude oil and natural gas. It has petroleum exploration licenses in India; and exploration and production blocks across Venezuela, Gabon, Myanmar, Nigeria, Libya, Mozambique, Bangladesh, th …
  • Marina Portoroz d.d.:企業の戦略・SWOT・財務情報
    Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report Summary Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • A. Menarini Diagnostics Srl:医療機器:M&Aディール及び事業提携情報
    Summary A. Menarini Diagnostics Srl (Menarini Diagnostics), a subsidiary of A Menarini Industrie Farmaceutiche Riunite Srl is a medical device company that offers in-vitro diagnostic products. The company provides pharmaceutical testing products including home glucose testing products, oral anticoag …
  • Tillotts Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Tillotts Pharma AG (Tillotts) a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products are used for the treatment of vari …
  • Tarsus Group Plc:企業のM&A・事業提携・投資動向
    Tarsus Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tarsus Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • NIH Office of Technology Transfer-製薬・医療分野:企業M&A・提携分析
    Summary NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biolog …
  • PolyNovo Ltd (PNV):企業の財務・戦略的SWOT分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, designs, develops and manufactures dermal regeneration solutions for various medical applications. The company offers NovoSorb BTM (Biodegradable Temporising Matrix), a synthetic, biodegradable and biocompatible device that facilitates the growt …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Eurofarma Laboratorios SA-製薬・医療分野:企業M&A・提携分析
    Summary Eurofarma Laboratorios SA (Eurofarma), formerly Bill Farmaceutica is a pharmaceutical company that manufactures and markets prescription, generic and veterinary drugs. The company offers prescription products which include aerosol ointment, alprazolam, acebrophylline, altiva, ebastel, fluoru …
  • Aequus Pharmaceuticals Inc (AQS):医療機器:M&Aディール及び事業提携情報
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • Asplundh Tree Expert LLC:企業の戦略的SWOT分析
    Asplundh Tree Expert LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Bonvests Holdings Limited:企業の戦略・SWOT・財務情報
    Bonvests Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bonvests Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Saracen Mineral Holdings Ltd:企業の戦略・SWOT・財務情報
    Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sharp HealthCare:企業の戦略的SWOT分析
    Sharp HealthCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • APEIRON Biologics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary APEIRON Biologics AG (APEIRON) is a clinical-stage biotechnology company that concentrates on the development of biological and immunological solutions for the treatment of various cancers. The company’s pipeline products include APN01, APN301, APN311, APN401, APN411, APN421 and APN431. Its …
  • Sanford Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding d …
  • Cell C (Pty) Ltd.:企業の戦略・SWOT・財務情報
    Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sino-U.S. United Metlife Insurance Co., Ltd.:企業の戦略・SWOT・財務分析
    Sino-U.S. United Metlife Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sino-U.S. United Metlife Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Kirayaka Bank, Ltd.:企業の戦略・SWOT・財務情報
    Kirayaka Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kirayaka Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆